| Company/Division name | Ratio Therapeutics Inc. with Wasatch Group |
| Parent company | Ratio Therapeutics Inc. with Wasatch Group |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2027 |
| City reshored to: | Salt Lake City |
| State(s) reshored to: | UT |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | radiopharmaceutical products |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Higher productivity, Impact on domestic economy, Infrastructure, Lean/other business process improvement techniques |
